Doctors really should look at whether their sufferers with fundamental NAION hazard aspects can be adversely affected by use of PDE5 inhibitors. Individuals who have previously seasoned NAION are at increased danger of NAION recurrence. Consequently, PDE5 inhibitors, together with LEVITRA, must be made use of with warning in these patients and only